Cerenis completes Phase I trial for cardiovascular drug.....           Theranostics Health signs collaboration agreement with Duke University.....           Array and AstraZeneca announce Phase II cancer trial plans.....           Diagnostic Health appoints new COO.....           Aga Medical granted CE Mark for vascular device.....           Novavax completes enrollment for Phase I/IIa influenza trial.....           Sucampo granted validation for lubiprostone European marketing applications.....           WVU Faculty Cites 'Climate of Fear'.....           Pharmasset Commences Dosing R7128 For Chronic Hepatitis C Treatment.....           Salix files patent infringement lawsuit against Novel.....           Masimo granted clearance for hemoglobin monitoring technology.....           Pozen transfers Treximet IND and NDA to GSK.....           Adherex signs agreement for Phase III STS data.....           Critical Biologics initiates enrollment for Solinex trial.....           Bourne Partners acquires Theramed.....           Sinobiomed to initiate Phase II malaria vaccine trial.....           Applied Nanoscience expands patent portfolio.....           SynCo Bio completes manufacture of ActoGeniX's anti-inflammatory drug.....           Sirtex initiates pilot study for hepatocelluar carcinoma.....           Sonomax to raise $2 million in private placement.....           Cellceutix to advance head and neck cancer drug.....           ProCure Centers obtains additional $35 million in financing.....           Study likely spells end for anti-bleeding drug.....           ImClone initiates enrollment for Phase II liver cancer trial.....           Synvista initiates Phase II heart failure study.....           Biophan acquires patent portfolio of Nanoset.....           Akorn-Strides granted FDA clearance for flumazenil injection.....           PhotoMedex obtains FDA approval for Xtrac Velocity Laser.....           Spinal Restoration to initiate pilot study for Biostat System.....           Cipher submits revised NDA for CIP-Tramadol ER.....           Covidien launches hernia fixation device in Europe.....           Xtent announces positive results from drug eluting stent safety trial.....           Medimetriks launches operations.....           St Jude Medical initiates cardiac therapy study.....           Lundbeck introduces insomnia drug in Europe.....           AVI BioPharma's antisense drugs found effective against lethal virus.....           Qiagen and Geneart join hands to commercialize synthetic genes.....           StemCor wins grant for bone marrow harvesting device.....           Oncolytics to initiate Phase II trial of intravenous cancer therapy.....           Nestle and GE collaborate in health and nutrition diagnostics.....           AstraZeneca wins approval for bipolar disorder drug.....           Novosom obtains patents for Smarticles.....           Simcere granted Chinese approval for generic Biapenem injection.....           Synta Pharmaceuticals to Host First-Quarter 2008 Conference Call on May 14, 2008.....           Crucell initiates Phase II study of rabies combination therapy in Philippines.....           Crucell Q1 revenues surge.....           Aton Pharma signs distribution agreement with Meizler Biopharma.....           Medinol obtains CE Mark for Presillion Stent.....           Arbios to initiate pivotal trial for Sepet liver assist device.....           Vicor presents positive clinical trial results for cardiac device.....           Theratechnologies and PDC sign license agreement for women's health programs.....           Neuromonics names new CEO.....           SBIO granted orphan drug designation for anti-tumor drug.....           Calando obtains patent rights to RNAi technology in China.....           Forest and Daiichi terminate Azor co-promotion agreement.....           Argos starts Phase II proof-of-concept trial for HIV drug.....           Novelos presents positive results from Phase II breast cancer trial.....           OmniSonics enrolls first patient in Sonic II Registry trial.....           GlaxoSmithKline granted European approval for lung cancer drug.....           Ranbaxy and Merck sign drug discovery agreement.....           NovaBay reports promising results from Phase I study of Aganocide compound.....           VGX signs production agreement to support cystic fibrosis trials.....           Nventa presents additional positive data from Phase I neoplasia trial.....           New ABPI Code focuses on relationships and ADRs.....           Pharmasset Selected to Join the NASDAQ Biotechnology Index.....           Pipex's pulmonary fibrosis drug granted orphan designation.....           Warner Chilcott and Leo Pharma obtain FDA approval for Taclonex Scalp.....           Intercell to acquire Iomai.....           Thallion to start Phase II brain cancer trial in Canada.....           Medarex starts Phase II trial of anti-inflammation drug.....           Proteome Sciences partners with EU for developing alternatives to animal tests.....           ProStrakan reports encouraging results from Fortigel study.....           ABR-Affinity BioReagents expands distribution partners in Europe.....           FDA approves Novo Nordisk's clot therapy.....           Progenics Q1 loss widens.....           Affymax Q1 net loss rises.....           Repros Q1 revenues fall by 15%.....           Warner Chilcott Q1 revenues rise.....           Javelin to raise $27.6 million in direct offering.....           Canadian Court dismisses patent lawsuit against Boston Scientific.....           Jazz secures $75 million in equity financing.....           Atrium granted approval for hernia repair devices.....           Enterix launches point-of-care cancer screening test.....           CorMatrix granted approval for cardiac implant.....           APP Pharmaceuticals posts rise in Q1 revenues.....           Par Pharmaceutical to Host First Quarter 2008 Earnings Conference Call on May 9 at.....           Barr Announces Approval Of Generic Yasmin.....           Barr sees downturn for 1Q.....           AIG loss, oil, drug firms rattle investors.....           LifeCycle Pharma's dyslipidemia drug found effective in Phase II study.....           Dor BioPharma acquires option for anthrax vaccine from Harvard University.....           BiPar to initiate Phase II ovarian cancer trial.....           Dana-Farber Institute partners with EntreMed in Phase I cancer study.....           Osiris wins approval for Prochymal expanded access program.....           OrthoLogic completes dosing in Phase I dermal scarring trial.....           FDA to boost post marketing safety activities.....           Uluru to launch Altrazeal wound care dressing.....           Collegium presents positive clinical data for oral oxycodone formulation.....           US WorldMeds develops dantrolene sodium injection for hyperthermia.....           Next Pharma's Relora relieves short-term anxiety in healthy women.....           Alpharma presents safety and efficacy data for pain drug.....           Metametrix launches new urinary diagnostic profile.....           Roche's Actemra found effective in arthritis trial.....           Cytopia and Cancer Therapeutics join hands in drug discovery.....           Eusa Pharma acquires Cytogen.....           Ziopharm granted orphan designation for palifosfamide.....           Invitrogen and WARF sign licensing agreement.....           Inverness Medical acquires Matria Healthcare.....           UK court rules against NICE over Alzheimer's guidance.....           Otsuka and Bristol-Myers obtain expanded approval for Abilify.....           Cardima raises $5 million in private placement.....           NuVasive to acquire Osteocel business from Osiris.....           Eli Lilly's Strattera wins FDA approval for maintenance of ADHD.....           Globus Medical completes enrollment for cervical disc clinical trial.....           Degree Scandal Sparks Rare Forum.....           Barr Pharma shares drop after guidance cut, downgrade.....           Cleveland BioLabs completes enrollment for Phase II prostate cancer trial.....           AMDL signs LOI to acquire GLP.....           iCo acquires rights to oral antifungal drug.....           VioQuest granted patent for dermal drug.....           Pipex granted notice of allowance for Alzheimer's drug patent.....           COTI granted European patent for leukemia drugs.....           Acucela files IND application for ocular drug.....           Cynosure wins Korean approval to market Accolade.....           Mylan granted approval to market generic Requip.....           Lipid Sciences granted two new patents.....           Enzon to spin off biotechnology business.....           Astellas's antifungal drug receives European approval.....           Microbix to acquire urokinase from ImaRx.....           ArthroCare's Topaz MicroDebrider found effective against tendon disorders.....           NationsHealth and CIGNA amend preferred vendor agreement.....           Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks........           FDA accepts Osteologix's IND application for osteoporosis drug.....           Fougera granted approval to market generic scalp solution.....           REGiMMUNE raises $8 million in series B financing.....           Pluristem granted approval to conduct arterial disease trials.....           Stanford University to study Pathwork's diagnostic test.....           NovaDel to raise $4 million in financing.....           Vascular Insights wins clearance to market infusion catheter.....           Dilon granted CE Mark for imaging system.....           Clarient partners with JVHL to offer cancer assays.....           Orexigen completes enrollment in Phase III study of obesity drug.....           Catalyst selects new drug candidate for hemophilia program.....           MacroGenics names new CFO and chief commercial officer.....           FDA accepts Osteologix's IND application for osteoporosis drug.....           Poniard completes enrollment of Phase II colorectal cancer trial.....           SDI signs supply agreement with University of North Carolina.....           Clarient partners with JVHL to offer cancer assays.....           Catalyst selects new drug candidate for hemophilia program.....           Dalton Pharma signs licensing agreement with Thermo Fisher Scientific.....           Novartis's meningitis vaccine found effective in Phase III trial.....           NicOx reports encouraging results from Phase IIa glaucoma trial.....           Health Discovery signs LoI with DCL to develop cancer test.....           Peak's tissue dissection tool found effective in preclinical studies.....           Spectrum receives $20 million cash payment from Par Pharmaceutical.....            
Chairmans Report
  Professional Pharmaceutical Scientist

If you are reading this, you are probably aware that the Academy of Pharmaceutical Sciences is an association of scientists (clinical and non-clinical) who apply their academic learning and professional training to further the development of safe and effective medicines. Consequently, pharmaceutical scientists come from a multitude of different academic backgrounds and are, more often than not, members of at least one other ‘learned society’ related to their specific educational training.

Read more >>   

APS quick links
Search for:
Future Events Focus Groups Vacancies
The Academy of Pharmaceutical Sciences organises several major conferences...

Read more >>   

Programme of Future Events
26 June 2008
"Extreme Characterisation"
Hazelrigg Hall, Loughborough University
To find out more about a focus group click on the appropriate link below.:
 
Biopharmaceutics
Compaction
Film Coating
Inhalation
Material Sciences
New Scientists
Pharmaceutical Colloids
Pharmacognosy
Process Engineering and Product Formulation
Skin
Therapeutic Biomolecules and Vaccines
Employment vacancies are displayed here as soon as they become available.

Please mention the APS when applying for any vacancy listed on theses pages.

View all Vacancies

Advertise a Vacancy

See all event dates >>   

View all Focus Groups >>   

 

Registered in England. No 4245751. Registered Office: 840 Melton Road, Thurmaston, Leicester, LE4 8BN